Viewing nowTobastine Tablet (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 200706537 · Notified 2007.06.07 · Insurance code 693900570
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. Specifically, it decreases the risk of myocardial infarction and stroke in adult patients with multiple risk factors for coronary artery disease and in patients with type 2 diabetes, and it also lowers the risk of vascular interventions and angina. Additionally, it is effective in reducing the risk of non-fatal myocardial infarction, fatal and non-fatal stroke, vascular interventions, hospitalizations due to congestive heart failure, and angina in patients who already have coronary artery disease. It is also used for the treatment of hyperlipidemia, lowering total cholesterol and LDL cholesterol levels, while raising HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It assists in reducing total cholesterol and LDL cholesterol levels as a dietary supplement for pediatric patients with heterozygous familial hypercholesterolemia. Therefore, it is used to improve the risk of cardiovascular diseases and hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring greater reductions in LDL cholesterol, treatment may be started at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients 70 years of age and older are similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administering doses higher than 20 mg of this medicine in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This drug may cause muscle-related symptoms; if severe muscle pain or weakness occurs, you must stop taking it immediately and consult your doctor. This drug should not be administered to patients with poor liver function or liver disease, and regular liver function tests should be conducted. Women who are pregnant, may become pregnant, or are breastfeeding should not use this medication, and women of childbearing age should practice appropriate contraception while receiving treatment. This drug may interact with certain medications, so if you are taking other drugs, it is essential to inform your doctor or pharmacist, especially when combined with medications affecting liver metabolism. This medication is not used for children, especially for those under 10 years old. Elderly patients are at increased risk for muscle-related side effects when taking this medication, thus observing them closely is necessary. In case of overdose, there is no specific antidote, so treatment should follow symptomatically while closely monitoring liver function and muscle condition. When storing this medication, keep it out of reach of children and store it in the original container. If symptoms such as muscle pain, fever, or weakness occur during treatment, immediately inform healthcare personnel and undergo examination. If a rash or blisters develop on the skin, or if a severe allergic reaction occurs, discontinue use immediately and seek medical attention.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is advisable to keep the storage temperature between 1 to 30 degrees Celsius to ensure the medication's effectiveness and safety are maintained over time.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.